Trials / Unknown
UnknownNCT04768595
Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)
A Nutritional, Placebo Controlled, Randomised, Blinded Study of the Effect of Different Fish Oils on Omega-3 Index (CetoIndex)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (estimated)
- Sponsor
- Epax Norway AS · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The study determines the EPA DHA uptake from different omega-3 supplements against a control.
Detailed description
The chronic uptake of omega-3 fatty acids EPA and DHA are commonly determined by measurement of EPA and DHA in red bloods cells and presented as a % of total fatty acids, the so-called Omega-3 Index. The index is a validated risk assessment for cardiovascular disease. Different fish oils may influence the Omega-3 Index differently depending on their composition. This study assesses omega-3 commonly found as a supplement vs a fish oil based on north atlantic fish species.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | Two, 1g capsules taken daily with food |
| DIETARY_SUPPLEMENT | Ceto 10 | Two, 1g capsules daily with food |
| DIETARY_SUPPLEMENT | Fish oil | Two, 1g capsules daily with food |
Timeline
- Start date
- 2021-03-03
- Primary completion
- 2021-06-30
- Completion
- 2021-08-01
- First posted
- 2021-02-24
- Last updated
- 2021-02-24
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT04768595. Inclusion in this directory is not an endorsement.